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difficile toxin and/or antigen in stool specimens
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Objective To evaluate six commercially available assays for the detection of Clostridium difficile toxin andlor
antigen in stool samples: one latex agglutination test (Culturette brand CDT, Becton Dickinson), two ELISAs
(Culturette brand Toxin CD, Becton Dickinson, and Ridascreen C. difficile Toxin AlB, R-biopharm), two
chromatographic assays (Clearview C. difficile A, Oxoid, and ColorPac Toxin A, Becton Dickinson) and one
enzyme immunoassay for the simultaneous detection of C. difficile common antigen and toxin A (Triage C.
difficile Panel, Biosite).
Methods Over a period of 3 months, 366 liquid or semi-liquid stool samples were tested using cell-culture
cytotoxin assay as standard, ethanol shock stool culture and latex agglutination (Culturette brand CDT). Of
these, 78 samples, positive with at least one of these three methods, and 98 randomly selected negative samples
were further evaluated using the other five kits. PCR was also performed on positive cultures to confirm the
presence of toxin A and B genes.
Results Triage C. difficile Panel had the best sensitivity (95%), followed by Clearview C. difficile and ColorPac
Toxin A (both 89%), Culturette brand Toxin CD (73%), Ridascreen C. difficile Toxin AlB (57%) and Culturette
brand CDT (23%). For Triage, the sensitivity of C. difficile antigen detection was 93%, and the sensitivity oftoxin
detection was lower (77%). Most false-positive results were obtained with the Triage C. difficile Panel (25
specimens) and Clearview C. difficile A (20 specimens). Culturette brand CDT had the best specificity (99%);
followed by Ridascreen C. difficile Toxin AlB (97%), Culturette brand Toxin CD (95%), ColorPac Toxin A
(89%), Clearview C. difficile A (83%) and Triage C. difficile Panel (75%). The positive predictive values ranged
from 68% to 94%, and the negative predictive values from 83% to 98%.
Conclusions The sensitivity is much higher for Triage and the two new chromatographic assays than for the
conventional ElAs. These tests also have a high negative predictive value. For Triage, C. difficile antigen-positive,
toxin A-negative results can be obtained; the clinical value of these must be established by additional studies.
Overall, the new-generation assays are still less sensitive than the cytotoxin assay; however, they provided same-
day results, could be used as a screening test and may be useful in laboratories without tissue-culture facilities.
Our results do not allow the recommendation of one single assay for the diagnosis of C. difficile-associated
diarrhea. It remains the case that laboratory results must be correlated and interpreted with the clinical
presentation of the patient.
Keywords Clostridium difficile, antigen, toxin
Accepted 30 October 2000
Clin Microbiol Infect 2001; 7: 55-64
INTRODUCTION
Clostridium difficile is a causative agent of various clinical syn-
dromes, ranging from asymptomatic colonization via mild
antibiotic-associated diarrhea (AAD) to pseudomembranous
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colitis (PMC), which can progress to toxic megacolon and
subsequent death [1]. C. difficile is associated with 90-100%
of cases of PMC, 60-75% of antibiotic-associated colitis and
11-33% of antibiotic-associated cases of diarrhea [2,3].
The organism produces at least two toxins, toxin A and toxin
B, which have been well characterized [4,5]. Toxin A is a potent
enterotoxin that is lethal and cytotoxic. Toxin B is also lethal but
is much more cytotoxic than toxin A. Although the exact
mechanisms by which these toxins cause damage to colonic
mucosal cells are unknown, it is thought that the toxins can act
synergistically [6] and playa major role in the diarrhea and
colitis caused by C. difficile.
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C. d!fficile-induced diarrhea or colitis is suspected in patients
who develop diarrhea during or after treatment with antimi-
crobial agents. The currently available methods that can be used
to aid in the diagnosis of C. d!fficile-related disease include
colonoscopy, cell-culture cytotoxicity assay, isolation of toxi-
genic C. d!fficile from stool specimens, immunodiagnostics
including latex agglutination or enzyme immunoassays (EIA),
and molecular techniques such as PCR.
Of these approaches, colonoscopy is rapid, but is invasive,
expensive and ouly specific in rare cases of PMC. The cell-
culture cytotoxicity assay is still considered to be the standard for
the detection of C. d!fficile toxins. However, this assay can give
false-negative results due to the susceptibility of toxin B to
degradation by proteases [7]. In contrast to the cell-culture
cytotoxicity assay, the presence of C. d!fficile in stool specimens
can easily be demonstrated by using culture media based on the
formula described by George et al [8], but culture requires 48 h
of incubation prior to identification and does not differentiate
toxigenic from non-toxigenic strains.
Recently, several immunoassays and chromatographic assays,
primarily for the detection of toxin A, have been introduced
which reduce the detection time. These tests are not only much
quicker than the cell-culture cytotoxicity assay in yielding a
result, but are also easy to perform and suited to single or batch
testing.
For years, the latex agglutination assay (Culturette brand
CDT test; Becton Dickinson, Cockeysville, MD) was used in
our laboratory for the detection of C. d!fficile toxin, although we
knew that the antigen used in this assay has been identified as the
enzyme glutamate dehydrogenase (GDH) [9,10] and is present
in all C. d!fficile isolates, regardless of their toxin-producing
ability. Over the years, many EIAs with different performances
have been described in the literature. With the development of
new-generation immunoassays, we were hoping to replace the
latex agglutination assay with a more sensitive and specific assay.
Therefore, we evaluated the performance of six commercial
assays for the detection of C. d!fficile toxin and/or antigen in
stool specimens against the cell-culture cytotoxicity assay. Dis-
crepant results were resolved by PCR on positive cultures to
confirm the presence of toxin A and B genes.
MATERIALS AND METHODS
Study protocol
Over a period of 3 months, January 1999 to March 1999, 366
liquid or semi-liquid stool specimens, submitted to the Labora-
tory for Bacteriology and Virology of the University Hospital
Ghent with a request for C. d!fficile toxin detection, were
included in the study. The stool specimens were refrigerated
at 4 "C until tested. Testing of the specimens using cell-culture
cytotoxicity assay, ethanol shock stool culture and latex agglu-
tination (Culturette brand CDT) was performed within 24 h of
receipt of the specimens in the laboratory. All specimens were
also stored at - 70°C until further testing with the other
commercial assays and/or PCR. The 78 samples positive with
at least one of these three methods and 98 randomly selected
negative samples were further evaluated using the other five kits.
Ethanol shockstoolculture
All stool specimens were prepared by ethanol shock treatment
[11], inoculated onto a selective medium composed of C.
d!fficile agar base (Oxoid, Basingstoke, UK), supplemented with
taurocholate (1 giL), cycloserine (500 mg/L) and cefoxitin
(16 mg/L), and incubated anaerobically at 37°C for 48 h
[12]. C. d!fficile was identified by characteristic colonial mor-
phology, Gram stain, fluorescence when exposed to ultraviolet
light (360 nm) and Amplified rDNA-restriction analysis
(ARDRA) [13].
Cell-culture cytotoxicity assay
Stool specimens were diluted in phosphate-buffered saline
(1 : 10, w/v) and centrifuged at 13 000 g for 10 min. The
supernatant was inoculated onto a cultured monolayer of
human lung fibroblasts and incubated at 37°C in a 6.5%
CO2 atmosphere. Screening for cytotoxicity was performed
at stool dilutions of 1 : 100. After 24 hand 48 h of incubation,
samples were considered positive in the cytotoxicity assay if a
characteristic cytopathic effect (cell rounding) was observed and
could be neutralized with anti-c. sordellii antiserum (ILS,
Tienen, Belgium). Neutralization was performed at a final
dilution of 1 : 150.
Culturette brand COT latex agglutination test
The Culturette brand CDT test, a latex agglutination test for
the detection of a C. d!fficile-associated antigen [9], was per-
formed according to the manufacturer's instructions by mixing
about 0.5 g of stool with an equal volume of buffer, vortexing
and centrifuging the mixture, and testing one drop of the
supernatant.
Culturette brand Toxin CD test
The Culturette brand Toxin CD test (Becton Dickinson,
Cockeysville, MD) is a 70-min EIA for the direct detection
of C. d!fficile toxin A in stool specimens. The test utilizes an
antitoxin A capture antibody coated on microwells. The patient
sample (and controls) and an enzyme-conjugated antitoxin A
detector antibody are added to the microwells and incubated at
37°C for 1 h. If the toxin A is present, a reactive antitoxin
enzyme complex develops. After washing to remove unbound
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conjugate, a substrate and a chromogen are added and incubated
at room temperature for 10 min. Color develops in the presence
of bound enzyme and is read spectrophotometrically at a dual
wavelength of 450/630 nm.
Ridascreen C. difficile Toxin AlB EIA
The Ridascreen C. difficiZe Toxin AlB EIA (R-Biopharm
GmbH, Darmstadt, Germany) is an EIA providing monoclonal
antibodies for simultaneous and specific detection of toxin A
and toxin B of C. difficiZe in stool specimens. The test was
performed according to the manufacturer's instructions. Inter-
pretation of test results was by spectrophotometric reading at a
dual wavelength of 450/630 nm.
The Clearview C. difficile Toxin Atest
The Clearview C. difficiZe Toxin A test (Oxoid, Basingstoke,
UK) is a new 30-min EIA and was performed according to the
manufacturer's instructions. A fecal sample is mixed with the
diluent and centrifuged for 10 min, and an aliquot of the
supernatant is added to the test unit. Blue latex particles within
the test device, sensitized with antibodies specific to C. diffu:ile
toxin A, link to toxin A within the sample and migrate along the
test strip. The latex-toxin complexes are then trapped by
immobilized antitoxin A antibodies beneath the result window,
forming a clearly visible blue line, indicating a positive result. In
the absence of C. difficiZe toxin A, complexes do not form and
the line does not appear. A blue control line should appear,
indicating that the device has performed correctly.
ColorPac Toxin A test
The ColorPac Toxin A test (Becton Dickinson, Cockeysville,
MD) is a rapid chromatographic assay for the qualitative
detection of C. difficiZe toxin A in stool specimens, and was
performed according to the manufacturer's instructions. The
ColorPac Toxin A test is composed ofa capture C. difficiZe toxin
A antibody immobilized on a chromatographic test strip. A
diluted specimen is added to the sample well of the test device
and moves up the test strip by capillary action. If toxin A is
present, it binds to the capture antibody at the test line; after
washing and adding two detector reagents (toxin A antibody-
coated liposomes containing a pink dye and a second liposome
reagent), a pink test line and a pink control line will appear,
indicating a positive result. In the absence of toxin A, ouly the
pink control line will appear, indicating a negative result.
The Triage C. difficile Panel
The Triage C. difficiZe Panel (Biosite Diagnostics, San Diego,
CA, USA) is an EIA for the simultaneous detection of the C.
diffu:iZe common antigen (glutamate dehydrogenase) and toxin A
in fecal specimens and was performed according to the man-
ufacturer's instructions. C. difficiZe common antigen andlor
toxin A present in stool specimens is isolated and immobilized
on a membrane with the use of specific antibodies. The
immobilized antigens are incubated with an antibody-enzyme
conjugate that binds to specific sites on the antigen. After
addition of the wash and substrate reagents, the common
antigen and toxin A are detected visually by the presence of
a purple-black color bar in the detection zone. A purple-black
color bar on both positive control zones should appear, indicat-
ing that the test has performed correctly.
Polymerase chain reaction
Identification of the C. difficiZe strains was done by ARDRA
[13]. The amplification was done by PCR with the primers
lXf3NOT (AGT TTG ATC CTG GCT CAG) and roMB (TAC
CTT GTT ACG ACT TCG TCC CAl. The amplicon gen-
erated by this PCR is approximately 1500 bp, and successful
amplification was checked by 1% agarose gel electrophoresis
and staining with ethidium bromide. Restriction endonuclease
digestion was carried out for 1 h at 37°C in 20-J-lL volumes
containing 10 J-lL of PCR product and 10 units of the AZul
restriction enzyme. Restriction fragment profiles were analyzed
by 2.5% agarose gel electrophoresis of 10 J-lL of restriction
mixture, and the profiles were compared visually with reference
profiles.
The two PCR procedures used to differentiate the C. difficiZe
strains into toxigenic and non-toxigenic strains were performed
as described by Kato et al [14,15].
The first PCR used the primers NK 2 (CCCAATAGAA-
GATTCAATATTAAGCTT) and NK 3 (GGAAGAAAA-
GAACTTCTGGCTCACTCAGGT) derived from the non-
repeating region of the C. difficiZe toxin A gene. Amplification
indicates the presence of the toxin A gene. The second PCR
used the primers NK 9 (CCACCAGCTGCAGCCATA) and
NK 11 (TGATGCTAATAATGAATCTAAAATGGTAAC)
derived from the repeating region of the C. difficiZe toxin A
gene. The amplification product derived from this PCR is
1200 bp when the strain is toxin A+ and toxin B+, and is
700 bp when the strain is toxin A- and toxin B+.
Data analysis
Performance statistics were calculated as described by Galen and
Gambino [16].
RESULTS
Cell-culture cytotoxicity assayresults
In total, 56 (15.3%) stool specimens were positive for C. difficiZe
toxin by cell-culture cytotoxicity testing. Of the 56 stool
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specimens, 51 were detected at the 24-h reading and five were
detected at the 48-h reading. For all these specimens except one
(not cultured), positive cytotoxicity was confirmed by positive
stool culture and PCR confirmed the presence of toxin A+,
toxin B+ strains. Another six specimens were cytotoxin assay
negative, but C. difficile was recovered from the culture and the
presence of the toxin A-t-, toxin B+ strains was confirmed by
PCR.
Performance characteristics
A common convention when evaluating new methods for the
detection of C. difficile has been to compare the results with the
cell-culture cytotoxin assay,considered as the standard [17]. The
performance characteristics of ethanol shock stool culture and
the different commercial assays are presented in Table 1. The
sensitivity and specificity for ethanol shock stool culture were
98% and 93%, respectively. For the commercial assays, Triage C.
difficile Panel had the best sensitivity (95%), followed by Clear-
view C. difficile A and ColorPac Toxin A (both 89%), Culturette
brand Toxin CD (73%), Ridascreen C. difficile Toxin AlB (57%)
and Culturette brand CDT (23%). For Triage, the sensitivity of
detection of C. difficile antigen was 93%, while the sensitivity of
detection of the toxin was lower (77%). Most false-positive
results were obtained with the Triage C. difficile Panel (25
specimens) and Clearview C. difficile A (20 specimens). Cultur-
ette brand CDT had the best specificity (99%); followed by
Ridascreen C. difficile Toxin AlB (97%), Culturette brand Toxin
CD (95%), ColorPac Toxin A (89%), Clearview C. diffu:ile A
(83%) and Triage C. difficile Panel (75%). For Triage, the
specificity for detection of C. difficile antigen was 75%, while
the specificity for detection of the toxin was higher (97%). The
positive predictive values range from 68% to 94%, and the
negative predictive values from 83% to 98%.
Indeterminate results and interpretation difficulties
With the Culturette brand Toxin CD, 15 of 176 specimens
(19.7%) had indeterminate results using the interpretation
criteria according to the manufacturer's instructions.
Resolution ofindeterminate results was performed by changing
the criteria (negative = OD450/630 < 0.07; indeterminate =
OD450/630::;' 0.07 but <0.1; positive = OD450/630 ::;, 0.1) to
negative = OD450/630 < 0.07 and positive = OD450/630
::;, 0.07; both positive and negative results were ob-
tained. The sensitivity for Culturette brand Toxin CD in-
creased from 73% to 79%, and specificity decreased from
95% to 93%.
Interpretation difficulties occurred with the new cartridge
and membrane assays. Because ofthe appearance ofa sometimes
very discrete line and the difference in intensity that occurs
between the lines in the result and control windows, there may
be some difficulties in interpreting the result of the Clearview
C. difficile A assay. Of the 176 samples tested with the ColorPac
Toxin A assay, four samples were wrongly interpreted as positive
due to the appearance ofan abnormally thin line, different from
true positives and ouly seen by the experienced technicians.
After retesting of these samples, the results were negative. With
the Triage C. difficile Panel assay, some stool samples can give a
dark background of the detection zone, which obscures the
visual appearance of any of the discrete zones. With the use of
this assay in our study, one of156 specimens (0.6%) had an initial
indeterminate result and required repeated testing; the speci-
men retested positive.
Detection bypolymerase chain reaction
Results of cell-culture cytotoxicity assay and PCR for the
repeating and non-repeating regions of the toxin A gene for
the culture-positive stool specimens are presented in Table 2.
Of the 56 positive cell-culture cytotoxicity assays, 55 strains
were cultured by ethanol shock stool culture. Of these, 54
strains were correctly identified by PCR as being toxin A+,
toxin B+C. difficile strains, and one strain was identified as C.
innocuum. Ofthe samples with negative cell-culture cytotoxicity
assays, 17 C. difficile strains, one C. innocuumstrain and one C.
butyricum strain were cultured by ethanol shock stool culture. Of
the 17 C. difficile strains, 11 strains were identified by PCR as
being toxin A-, toxin B- strains. The other six strains were
identified by PCR as being toxin A+, toxin B+C. difficile. The
results of the different commercial assays for these six stool
samples are summarized in Table 3. Only Clearview C. diffu:ile
A detected the presence of toxin A in two samples. Triage C.
difficile Panel was able to detect C. difficile antigen but not toxin
A in all six stool samples. The results of Triage correlate
perfectly with the results of stool culture and the cell-culture
cytotoxicity assay. In our study, we found no toxin A-, toxin B+
C. difficile strains.
DISCUSSION
The cell-culture cytotoxicity assay is still considered to be the
standard for the detection of C. difficile toxin B in stool speci-
mens because of its high sensitivity « 1 pg of toxin B) and
specificity (neutralization of the cytopathic effect by a specific
antiserum) [18]. The sensitivity of the assay, however, may be
compromised because of the susceptibility of toxin B to degra-
dation by proteases in the stool. In our study, six strains, for
which the cell-culture cytotoxicity assay performed on stool
samples was negative, were identified by PCR as being toxin
A+, toxin B+ C. difficile. Therefore, it could be reasonable to
adapt the standard with the PCR for the detection of toxigenic
C. difficile. Moreover, the cell-culture cytotoxicity assay is also
time-consuming (up to 48 h of incubation), has never been
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fully standardized, and is beyond the capability of many labora-
tories. Protocols in different laboratories vary in the cell lines
used and in the dilutions of stool tested. On the other hand, the
purification of toxin A and B has permitted the production of
monoclonal antibodies against these toxins and the develop-
ment of new and rapid immunoassays to detect these toxins in
stool specimens.
Isolation of C. difficile from stool culture approaches 98%
sensitivity. This, in agreement with other reports, confirms that
culture is a very sensitive method [19,20]. On the other hand,
culture requires 48 h of incubation and does not differentiate
toxigenic from non-toxigenic strains, although we found a
specificity of 93%. Stool culture in combination with PCR
differentiates toxigenic from non-toxigenic strains, but fails to
distinguish between carriage and in vivo toxin production.
In this study, we compared six commercial assays with the
cell-culture cytotoxicity assay. The performance characteristics
of the tests are listed in Table 1. The latex agglutination test
Culturette brand CDT, with a specificity of 99%, had a sensi-
tivity of only 23%. This result is extremely low compared to
recent reports that found the latex agglutination test to be
60-70% sensitive relative to the results of the standard [21,22]
and is in even greater contrast to earlier published sensitivities of
80-90% [20,23,24]. The reason for the low sensitivity of the
latex agglutination test is not known.
The sensitivity of the conventional EIAs, Culturette brand
Toxin CD and Ridascreen C. difficile Toxin AlB, could be
increased from 73% to 79% and from 57% to 66%, respectively,
by changing the interpretation criteria as described above,
without a great change in specificity.
Despite these modifications, the sensitivity remained low and
therefore these two EIAs do not appear sufficiendy sensitive for
accurate detection of C. difficile toxins.
The need for rapid, sensitive and accurate diagnostic tests has
encouraged the development of new immunoassays and chro-
matographic assays. These new assays enable results to be
obtained within 20-40 min of sample receipt and, with one
test per sample, there is no need to batch. Samples can be
analyzed individually as soon as they are received by the
laboratory. An internal control is incorporated in each test
device, so testing of additional controls is not needed. The
procedures are not labor-intensive, and so handling of larger
numbers of samples is not problematic. We note that the
sensitivity of these new assays is higher than those of the
conventional EIAs. Clearview C. difficile A and ColorPac Toxin
A both have a sensitivity of 89%. On the other hand, the
specificity of these new assays is lower than those of the
conventional EIAs. The interpretation of Triage is somewhat
more difficult, because this assay contains two different tests,
aimed at detection ofthe antigen and toxin A. The sensitivity of
detection of C. difficile antigen is high (93%), with a low
specificity (75%). On the contrary, the sensitivity of detection
of C. difficile toxin is low (77%), with a high specificity (97%).
These data are comparable to those published by Barbut et al
[25]. The combination of the antigen and the toxin in one test
increases the sensitivity to 95%, with a specificity of 75%. The
negative predictive value of the test is high (96%), but the
clinical siguificance of a sample yielding a C. difficile antigen-
positive, toxin A-negative result must be established by addi-
tional studies.
Although the new cartridge and membrane assays have the
advantage ofvisual reading compared to the conventional EIAs,
they all have their own interpretation difficulties. Sometimes it
is possible to resolve the reading problem by retesting a diluted
sample, which leads to a decrease in sensitivity and an increased
cost.
In determining C. difficile-associated disease, the relationship
between the laboratory results and the clinical diaguosis is not
always clearcut. Several pre-analytical factors, such as the col-
lection conditions ofstool samples, and the time and the storage
of the samples before arrival in the laboratory, can affect the
laboratory results and the clinical diaguosis [26]. In our patient
population, there was one patient with endoscopically con-
firmed pseudomembranous colitis for which culture, cytotoxin
assay and all commercial assays except one were negative. From
another patient with C. difficile-associated diarrhea, we received
three stool samples collected within a short period of time,
which were all culture positive and for which PCR confirmed
the presence oftoxin A-t-, toxin B+ C. difficile strains. Cytotoxin
assay detected C. diffu:ile toxin after 24 h of incubation in the
first sample, and after 48 h of incubation in the second sample,
but no toxin in the third sample. On the other hand, culture and
cytotoxin assays may be positive for patients without enteric
disease. Clinicians must use laboratory results in combination
with the patient's clinical history to make a final diagnosis.
Although the cell-culture cytotoxin assay-eventually com-
bined with the PCR-is the most sensitive and specific tech-
nique for detecting C. difficile toxin, rapid commercial tests are
more suited to situations where tests are infrequent or cell-
culture facilities are not available. Besides the performance of
the assay, the availability of the test and the use by clinicians are
aspects to consider. Elements important for decision-making are
summarized in Table 4.
It is obvious that the costs of the different assays can be
different in other countries and laboratories, and price data
should be adapted. The choice of test will also depend on the
technician time, workload and equipment of the laboratory.
Last but not least, the choice will be influenced by the use of
the test results or the response to the test results by the clinicians:
do we need immediate results or can we pool samples within a
24-h period or a weekend? Empirical therapy for C. difficile-
associated diarrhea is often started before test results, and once
empirical therapy is started, most physicians continue therapy
despite negative test results [27].
© 2001 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, GMI, 7, 55-64
©
N
<=>
'=
n
o
"C
-<
~
~
0,-
CD
~
o
"C
~
u:>g
~.
S,
Q
",'
ii'
0>
s:
ii'
o
co
o'
,g
-<
0>
=>
ci,
=>
~g"
'"D
Vi'
~
'"CD
.'"
.~
.....
on
!
...
0-,
N
Q
5'CS·
~
~
C"")
C3
~
Table 4 Elements for decision-making
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